Osteopenia and Oscal


Osteopenia Symptoms and Causes

Strong bones are important for your health. A bone mineral density (BMD) test is the best way to measure your bone health. It compares your bone density, or mass, to that of a healthy person who is the same age and sex as you are. It can show

  • Whether you have osteoporosis, a disease that makes your bones weak
  • Your risk for breaking bones
  • Whether your osteoporosis treatment is working

Low bone mass that is not low enough to be osteoporosis is sometimes called Osteopenia. Causes of low bone mass include family history, not developing good bone mass when you are young, and certain conditions or medicines. Not everyone who has low bone mass gets osteoporosis, but they are at higher risk for getting it.

If you have low bone mass, there are things you can do to help slow down bone loss. These include eating foods rich in calcium and vitamin D and doing weight-bearing exercise such as walking, tennis, or dancing. In some cases, your doctor may prescribe medicines to prevent osteoporosis.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Check out the latest treatments for osteopenia

osteopenia treatment research studies

Oscal clinical trials, surveys and public health registries

Find Drug Side Effect reports

Oscal Side Effects

Feeling Hot (5)
Fall (4)
Arthralgia (3)
Fatigue (2)
Diarrhoea (2)
Chills (2)
Flushing (2)
Cough (2)
Dyspnoea (2)
Pulmonary Embolism (2)
Haemorrhage (2)
Myalgia (2)
Nausea (2)
Sinusitis (2)
Hypertension (2)
Meniscus Lesion (1)
Micturition Urgency (1)
Medical Device Implantation (1)
Iron Deficiency Anaemia (1)
Movement Disorder (1)
Joint Crepitation (1)
Leukopenia (1)
Malaise (1)
Thrombosis (1)
Therapeutic Response Decreased (1)
Thrombocytopenia (1)
Injury (1)
Syncope (1)
Swelling Face (1)
Procedural Pain (1)
Surgery (1)
Infusion Site Pain (1)
Pain In Extremity (1)
Myocardial Infarction (1)
Osteonecrosis (1)
Osteonecrosis Of Jaw (1)
Nasopharyngitis (1)
No Adverse Event (1)
Oedema Peripheral (1)
No Therapeutic Response (1)
Osteopenia (1)
Pain (1)
Muscle Spasms (1)
Injection Site Erythema (1)
Injection Site Pain (1)
Musculoskeletal Pain (1)
Pigmentation Disorder (1)
Papule (1)
Pelvic Fracture (1)
Injection Site Swelling (1)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Can your body assimilate calcium with out magnesium????

Can oscal extra d cause ring of the ear???

Have others had their doctors do a bone mineral densiity test? I hsve osteopenia in some places and osteoporosis in others - and no other risk factors. It's all due to the use of the AEDs. I have checked the research. If you are on this long term

I have been diagnosed with osteopenia with one osteoporotic vertebra (the L4). I took my first Bonviva tablet last Friday. After 2 1/2 days of taking the tablet, I experienced diarrhoea and a severe ache that travelled from my stomach to my pelvic ar

I have been on Fosavance for almost two months now for osteopenia which was caused I think by Oopherectomy and Arimidex, now I am taking Fosavance as well in the hope that it will help me. But since taking it I have aches and pains everywhe

I have been taking epilim for bipolar disorder for 15 years now,it has help keep me relatively stable.However i have just been diagnosed with osteopenia, the first stages of osteoporosis.I am only 46 years old.I have just started an increased dose of

I have been using fosamax for years for osteopenia. I have good teeth with1 root canal. I am wooried about it affecting my teeth. Is taking it a major risk for teeth? Is there a better way to prevent bone loss? I am 64, good health and use weight tra

I just started Fosavance tablets for Osteopenia, I am suffering severe joint pain only in my shoulders, chest and back. It is prescribed by my doctor(orthopedic) What shall I do? Stop the medicine? If I continue will I have the same pain every week

P Can the prolonged use of pulmicort, used daily. Cause osteopenia?

Well i am surprised to read all the negative comments about Bonviva, i am 25 and have been diagnosed with osteopenia. I have been taking this medicine for the past 11 months and MashAllah i had no problems at all. No side effects whatsoever. In fact

Osteopenia Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Melatonin-Micronutrients for Osteopenia Treatment Study
Conditions: Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Fiber pill;   Drug: Strontium citrate/melatonin/Vitamins K2 and D3
Outcome Measure: Changes in bone mineral density from baseline to one year following treatment
2 Unknown  Classic Yin and Yang Tonic Formula for Osteopenia
Condition: Osteopenia
Interventions: Drug: Yin and Yang tonic granules;   Drug: placebo
Outcome Measures: bone mineral density;   pain visual analogue scales,ECOS-16 questionnaire,bone metabolism,NEI.
3 Recruiting Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
Conditions: HIV Infection;   Bone Loss;   Osteopenia;   Osteoporosis
Intervention: Drug: Zoledronic acid
Outcome Measures: C-terminal telopeptide of collagen (CTx);   Bone mineral density (BMD) by Dual-energy X-ray absorptiometry (DXA)-Scan, Cellular OPG/RANKL Expression
4 Unknown  Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
Condition: Osteopenia
Intervention: Other: exercise intervention
Outcome Measures: Bone Mineral Density;   Serum markers of bone turnover;   Serum hormones regulating bone turnover
5 Recruiting IGF-1 and Bone Loss in Women With Anorexia Nervosa
Conditions: Anorexia Nervosa;   Osteopenia;   Osteoporosis
Interventions: Drug: rhIGF-1;   Drug: Risedronate;   Drug: Placebo
Outcome Measures: Bone Mineral Density;   Bone Microarchitecture and strength
6 Not yet recruiting Bone Disease in Chronic Pancreatitis: A Complex Phenomenon
Conditions: Chronic Pancreatitis;   Osteopenia;   Osteoporosis
Outcome Measures: To define the prevalence of low bone density (Osteopenia or osteoporosis) in patients with chronic pancreatitis;   Prevalence of hypogonadism in patients with chronic pancreatitis.;   Hypogonadism and/or opioid medication use are independent risk factors for low bone density in patients with chronic pancreatitis.
7 Recruiting A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Conditions: Cancer;   Cataract;   Low Bone Mineral Density;   Osteopenia;   Osteoporosis;   Prostate Cancer
Interventions: Biological: Denosumab;   Biological: Placebo
Outcome Measure: Subject incidence of lens opacification event development or progression by month 12, based on a change of ≥ 1.0 in P, ≥ 1.0 in C, or ≥ 0.7 in NO in the LOCS III score.
8 Unknown  Use Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty
Condition: Periprosthetic Bone Loss in Total Knee Replacement
Intervention: Radiation: dual energy x-ray absorptiometry
Outcome Measure: change in bone mineral density
9 Recruiting Bone Health and Vitamin D Status
Conditions: Osteopenia;   Vitamin D Deficiency;   HIV Infection
Outcome Measures: Osteopenia;   vitamin D deficiency;   BMD
10 Not yet recruiting Healing of Bone/Soft Tissue to Different Abutment Biomaterials and the Impact on Marginal Bone Loss
Conditions: Bone Loss;   Inflammation
Interventions: Device: dental implants;   Device: Zirconia abutments;   Device: Titanium Abutments;   Device: acrylic abutments;   Device: cad-cam acrylic abutments;   Procedure: Subcrestal;   Device: platform-switch;   Procedure: one-time one-abutment;   Procedure: Torque 20 n/cm2
Outcome Measures: Gingival Inflammatory Changes from baseline to 12 weeks;   Marginal Bone Loss;   Gingival height;   Osseointegration;   Height from gingiva to abutment
11 Unknown  The Effects of Potassium Citrate on Bone Metabolism
Conditions: Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal
Intervention: Drug: potassium citrate
Outcome Measures: Bone turnover markers;   Bone Density by DEXA
12 Not yet recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
Outcome Measures: Variations from baseline in DEXA-measured bone mineral density (t-score, spine and femur);   variations from baseline in CTX (C-terminal telopeptide of type I collagen) and OC (Osteocalcin);   To assess the variation in renal function
13 Recruiting Bone Loss Treatment From Adjuvant Zoledronate Efficacy
Conditions: Breast Neoplasms;   Bone Loss
Intervention: Drug: Zoledronate
Outcome Measures: Change from Baseline in Bone Mineral Density;   Bone metastasis rate;   Disease-Free Survival
14 Unknown  Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
Conditions: Gaucher's Disease;   Osteopenia
Interventions: Drug: alendronate sodium;   Drug: calcium carbonate;   Drug: cholecalciferol
Outcome Measure:
15 Unknown  A Taiwan Isoflavone Multicenter Study (TIMS)
Conditions: Low Bone Density;   Osteopenia
Intervention: Drug: Soy Isoflavone
Outcome Measures: BMD change;   Lipid profile
16 Not yet recruiting Investigating a New Way of Giving Medicine to Newborn and Preterm Babies
Conditions: Hypophosphataemia;   Osteopenia of Prematurity
Interventions: Drug: Oral thin film therapy (Potassium acid phosphate oral thin films);   Drug: Standard therapy (Potassium acid phosphate oral solution)
Outcome Measures: Serum phosphate;   Age-appropriateness
17 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
Outcome Measures: Bone mineral density measurement of the Lumbar spine;   Bone mineral density of the femoral neck;   Bone mineral density of the radius;   Osteoprotegerin (OPG/OCIF);   RANKL (OPG-ligand);   cathepsin K (cat K);   ionised calcium (Ca++);   phosphate (PO4-);   alkaline phosphatase (AP);   bone-specific alkaline phosphatase (BAP);   osteocalcin (Oc);   parathyroid hormone (PTH)
18 Not yet recruiting Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
Conditions: Osteopenia;   Osteoporosis
Interventions: Drug: Pamidronate;   Drug: Calcium and vitamin D
Outcome Measures: Lumbar spine bone mineral content;   Total body bone mineral content (TBMC; excluding head; adjusted for height, age, sex, Tanner stage, and race);   Total bone mineral density (BMD), cortical BMD, trabecular BMD, and estimated bone strength measured by pQCT;   Cytokine levels (interleukin IL-6, IL-7, and TNF-α);   Receptor activator of the nuclear factor-κB ligand [RANKL], osteoprotegerin [OPG], RANKL/OPG ratio;   Markers of bone resorption (carboxy-terminal collagen crosslinks [CTX] and deoxypyridinoline [DPD]);   Markers of bone formation (procollagen type 1 N-terminal propeptide [P1NP] and osteocalcin [OCN])
19 Not yet recruiting Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients
Condition: Moderate to Advanced Chronic Periodontitis
Interventions: Drug: locally-applied minocycline HCl (1 mg);   Procedure: scaling and root planing (Sc/RP)
Outcome Measures: Interproximal bone height loss;   Interproximal Bone Loss;   presence of inflammatory biomarkers
20 Unknown  Alveolar Bone Loss Around 3 Different Designs of Dental Implant: Prospective Comparative Clinical Trail
Condition: Alveolar Bone Loss
Intervention: Device: oral implant
Outcome Measure: radiographic changes in the alveolar bone height around the oral implant till 12 m post loading